Haploinsuffciency for Znf9 in Znf9+/- Mice Is Associated with Multiorgan Abnormalities Resembling Myotonic Dystrophy

Journal of Molecular Biology

Volumn 368, Issue 1, 2007, Pages 8-17

  Chen, Wei ^a,b   Wang, Yucheng ^a,b   Abe, Yoko ^a   Cheney, Lukas ^a   Udd, Bjarne ^c,d,e   Li, Yi Ping ^a,b  

^a FORSYTH INSTITUTE   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c VAASA CENTRAL HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

electromyography; myotonic dystrophy; ZNF9 gene; Znf9 haploinsufficiency; Znf9+ mice

Indexed keywords

CHLORIDE CHANNEL;

ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAPHY; GENE; GENE EXPRESSION; GENETIC TRAIT; HEART MUSCLE; HEART MUSCLE CONDUCTION DISTURBANCE; HISTOLOGY; MORPHOLOGY; MOUSE; MULTIPLE ORGAN FAILURE; MYOTONIC DYSTROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; TRANSGENIC MOUSE; ZNF9 GENE;

MUS; MUS MUSCULUS;

EID: 33947321525     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.01.088     Document Type: Article

References (36)

1. Tapscott S.J. Deconstructing myotonic dystrophy. Science 289 (2000) 1701-1702
2. Day J.W., Ricker K., Jacobsen J.F., Rasmussen L.J., Dick K.A., Kress W., et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60 (2003) 657-664
3. Ricker K., Koch M.C., Lehmann-Horn F., Pongratz D., Otto M., Heine R., and Moxley III R.T. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44 (1994) 1448-1452
4. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293 (2001) 864-867
5. Bachinski L.L., Udd B., Meola G., Sansone V., Bassez G., Eymard B., et al. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am. J. Hum. Genet. 73 (2003) 835-848
6. Liquori C.L., Ikeda Y., Weatherspoon M., Ricker K., Schoser B.G., Dalton J.C., et al. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Am. J. Hum. Genet. 73 (2003) 849-862
7. Udd B., Meola G., Krahe R., Thornton C., Ranum L., Day J., et al. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands. Neuromuscul. Disord. 13 (2003) 589-596
8. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289 (2000) 1769-1773
9. Charlet B., Savkur R.S., Singh G., Philips A.V., Grice E.A., and Cooper T.A. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10 (2002) 45-53
10. Mankodi A., Takahashi M.P., Jiang H., Beck C.L., Bowers W.J., Moxley R.T., et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10 (2002) 35-44
11. Mankodi A., Urbinati C.R., Yuan Q.P., Moxley R.T., Sansone V., Krym M., et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 10 (2001) 2165-2170
12. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., et al. A muscleblind knockout model for myotonic dystrophy. Science 302 (2003) 1978-1980
13. Lu X., Timchenko N.A., and Timchenko L.T. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 8 (1999) 53-60
14. Miller J.W., Urbinati C.R., Teng-Umnuay P., Stenberg M.G., Byrne B.J., Thornton C.A., and Swanson M.S. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19 (2000) 4439-4448
15. Tian B., White R.J., Xia T., Welle S., Turner D.H., Mathews M.B., and Thornton C.A. Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA 6 (2000) 79-87
16. Mankodi A., Teng-Umnuay P., Krym M., Henderson D., Swanson M., and Thornton C.A. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann. Neurol. 54 (2003) 760-768
17. Ranum L.P., and Day J.W. Dominantly inherited, non-coding microsatellite expansion disorders. Curr. Opin. Genet. Dev. 12 (2002) 266-271
18. Mahadevan M.S., Yadava R.S., Yu Q., Balijepalli S., Frenzel-McCardell C.D., Bourne T.D., and Phillips L.H. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nature Genet. 38 (2006) 1066-1070
19. Cho D.H., and Tapscott S.J. Myotonic dystrophy: Emerging mechanisms for DM1 and DM2. Biochim. Biophys. Acta 1772 (2006) 195-204
20. Vihola A., Bassez G., Meola G., Zhang S., Haapasalo H., Paetau A., et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 60 (2003) 1854-1857
21. Ho T.H., Savkur R.S., Poulos M.G., Mancini M.A., Swanson M.S., and Cooper T.A. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J. Cell Sci. 118 (2005) 2923-2933
22. Flink I.L., and Morkin E. Alternatively processed isoforms of cellular nucleic acid-binding protein interact with a suppressor region of the human beta-myosin heavy chain gene. J. Biol. Chem. 270 (1995) 6959-6965
23. Chen W., Liang Y., Deng W., Shimizu K., Ashique A.M., Li E., and Li Y.P. The zinc-finger protein CNBP is required for forebrain formation in the mouse. Development 130 (2003) 1367-1379
24. Schoser B.G., Ricker K., Schneider-Gold C., Hengstenberg C., Durre J., Bultmann B., et al. Sudden cardiac death in myotonic dystrophy type 2. Neurology 63 (2004) 2402-2404
25. Schneider-Gold C., Beer M., Kostler H., Buchner S., Sandstede J., Hahn D., and Toyka K.V. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle Nerve 30 (2004) 636-644
26. Ranum L.P., and Day J.W. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Curr. Neurol. Neurosci. Rep. 2 (2002) 465-470
27. Ranum L.P., and Day J.W. Myotonic dystrophy: RNA pathogenesis comes into focus. Am. J. Hum. Genet. 74 (2004) 793-804
28. Udd B., Meola G., Krahe R., Thornton C., Ranum L.P., Bassez G., et al. 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul. Disord. 16 (2006) 403-413
29. Klesert T.R., Cho D.H., Clark J.I., Maylie J., Adelman J., Snider L., et al. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nature Genet. 25 (2000) 105-109
30. Sarkar P.S., Appukuttan B., Han J., Ito Y., Ai C., Tsai W., et al. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nature Genet. 25 (2000) 110-114
31. Konicek B.W., Xia X., Rajavashisth T., and Harrington M.A. Regulation of mouse colony-stimulating factor-1 gene promoter activity by AP1 and cellular nucleic acid-binding protein. DNA Cell Biol. 17 (1998) 799-809
32. Margolis J.M., Schoser B.G., Moseley M.L., Day J.W., and Ranum L.P. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum. Mol. Genet. 15 (2006) 1808-1815
33. Li Y.P., Chen W., Liang Y., Li E., and Stashenko P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nature Genet. 23 (1999) 447-451
34. Berul C.I., Aronovitz M.J., Wang P.J., and Mendelsohn M.E. In vivo cardiac electrophysiology studies in the mouse. Circulation 94 (1996) 2641-2648
35. Berul C.I., Christe M.E., Aronovitz M.J., Seidman C.E., Seidman J.G., and Mendelsohn M.E. Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice. J. Clin. Invest. 99 (1997) 570-576
36. Berul C.I., Christe M.E., Aronovitz M.J., Maguire C.T., Seidman C.E., Seidman J.G., and Mendelsohn M.E. Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities. J. Interv. Card. Electrophysiol. 2 (1998) 7-14